Archives
Press Releases
advertisement
June 27, 2018
- Omnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes.
- Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology; New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration.
- FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States.
- Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes.
- Existing drug preserves insulin production in new Type 1 diabetes cases, study finds. See also Kidney drug preserves insulin production in type 1 diabetes patients.
- Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA’s 78th Scientific Sessions.
- One Drop Announces Blood Glucose Prediction and Automated Decision Support.
May 23, 2018
- Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™️ Bionic Pancreas System. See also Beta Bionics receives FDA approval to begin bionic pancreas study recruitment.
- Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge; Revolutionary “smart” drug could prevent hypoglycemia in people with diabetes.
May 16, 2018
advertisement
